Notes from the study:
Patients implementing both treatments saw improved stability of the disease and lived longer
MalignantNoMore
Efficacy of monoterpene Perillyl alcohol upon survival rate of patients with recurrent glioblastoma
Notes from the study:
Those using Perillyl Alcohol Inhalation lived longer than those not using it
It can be used long-term with little-to-no side effects
Survival of glioma patients after complementary treatment with galactoside-specific lectin from mistletoe
Notes from the study:
Those receiving the Mistletoe Therapy took twice as long to show sign of disease recurrence
Those receiving Mistletoe Therapy lived twice as long as well
Metformin influences progression in diabetic glioblastoma patients
Notes from the study:
Metformin usage by diabetic patients was correlated with a higher percentage of desired outcomes
Increased survival time in brain glioblastomas by a radioneuroendocrine strategy with radiotherapy plus melatonin compared to radiotherapy alone
Notes from the study:
Melatonin supplementation led to both longer survival time and disease-free progression
Mebendazole and temozolomide in patients with newly diagnosed high-grade gliomas: results of a phase 1 clinical trial
Notes from the study:
Those taking Mebendazole for at least one month had a median progression-free survival of 13 months compared to 9 for the control group
2 patients are still alive and taking Mebednazole 6 years after the trial started
Radiotherapy Using IMRT Boosts After Hyperbaric Oxygen Therapy With Chemotherapy for Glioblastoma
Notes from the study:
Combining Radiation with Hyperbaric Oxygen Therapy Median increased overall median survival to 22.1 months
A novel lecithin-based delivery form of Boswellic acids as complementary treatment of radiochemotherapy-induced cerebral edema in patients with glioblastoma multiforme: a longitudinal pilot experience
Notes from the study:
The authors found a sizable proportion of those receiving Boswellia showed reduced edema